Elad Jacoby

Specialization: Pediatrician
20 years of experience
Speaks:
English, Hebrew
Online consultations: available
Workplace: Israel, Ramat Gan, Sheba Medical Center
A pioneer of CAR-T therapy in Israel, author of over 240 scientific publications, and head of a pediatric cell therapy center.
Dr. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby specializes in treating relapsed and high-risk pediatric leukemias and lymphomas. He completed fellowships at Johns Hopkins and the U.S. National Cancer Institute.
- Medical Director of the Advanced Biotherapy Center at Sheba Medical Center.
- Authored over 240 scientific publications in pediatric hemato-oncology.
- Board-certified in both Pediatrics and Pediatric Hematology and Oncology.
- Leads the integration of CAR T–cell therapy with bone marrow transplantation.

Online consultation with Elad Jacoby

Convenient and easy

100% secure and confidential

$1,900

How are we doing?

1 of 3

Information about this doctor is full and clear

Strongly disagree

Strongly agree

Qualifications

Prof. Elad Jacoby is a pioneer of pediatric CAR T–cell therapy in Israel. He heads the Pediatric Cell Therapy Center at Sheba Medical Center. Dr. Jacoby has authored over 240 scientific publications on advanced cellular medicine.

Specialization & Focus

Prof. Jacoby specializes in treating high-risk pediatric leukemias and lymphomas. He focuses on patients who have limited standard treatment options. The doctor integrates CAR T–cell therapy with bone marrow transplantation for complex spinal reconstruction and high-risk cases. He also uses precision medicine and immunotherapy to create individualized care plans.

His clinical expertise includes:

CAR T–cell therapy — a treatment that reprograms the immune system to fight cancer
Allogenic and autologous bone marrow and stem cell transplantation
Treatment of acute lymphoblastic leukemia (ALL) and aggressive lymphomas
Mitochondrial Augmentation Therapy for rare conditions
Advanced cellular immunotherapy including anti-viral T-cell therapies for immunocompromised patients

Achievements & Leadership

The specialist led one of the first national programs for pediatric leukemia. He is the Medical Director of the Advanced Biotherapy Center. Dr. Jacoby is an Associate Professor at Tel Aviv University. Additionally, he serves on the IBFM CAR T–Cell Taskforce to improve global treatment standards.

Work Experience

Head, Pediatric Cell Therapy Center, Sheba Medical Center
Medical Director, Advanced Biotherapy Center, Sheba Medical Center
Associate Professor, Tel Aviv University School of Medicine
Member, Institutional Review Board, Sheba Medical Center

Education & Training

Medical Degree – Tel Aviv University School of Medicine
Pediatrics Residency – Sheba Medical Center
Fellowship in Pediatric Hematology & Oncology – Johns Hopkins Hospital, USA
Clinical & Research Fellowship – National Cancer Institute (NCI), USA

Research & Publications

Prof. Jacoby leads international clinical trials for next-generation cancer therapies. He collaborates with Johns Hopkins Hospital and the National Cancer Institute. His research focuses on immune system modulation and mitochondrial medicine. Furthermore, he has contributed to over 240 published peer-reviewed studies.

Professional Memberships & Certifications

Board-certified in Pediatrics
Board-certified in Pediatric Hematology and Oncology
Member, IBFM CAR T–Cell Taskforce